Analyst Price Targets — NLCP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 12, 2025 2:48 pm | Craig Kucera | UBS | $16.00 | $13.15 | TheFly | NewLake Capital Partners upgraded to Buy at Lucid on potential cannabis reform |
| December 12, 2025 2:45 pm | Craig Kucera | Capital One Financial | $16.00 | $13.18 | TheFly | NewLake Capital Partners upgraded to Buy from Neutral at Lucid Capital |
| December 12, 2025 2:43 pm | Craig Kicera | Loop Capital Markets | $16.00 | $13.28 | StreetInsider | NewLake Capital Partners Inc. (NLCP) PT Raised to $16 at Lucid Capital Markets, Upgrades to Buy |
| May 13, 2024 7:42 am | Merill Ross | Compass Point | $23.50 | $20.36 | StreetInsider | NewLake Capital Partners Inc. (NLCP) PT Raised to $23.50 at Compass Point |
| March 14, 2024 5:12 am | Merill Ross | Compass Point | $18.25 | $16.41 | StreetInsider | Compass Point Upgrades NewLake Capital Partners Inc. (NLCP) to Buy |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for NLCP

Many investors still misunderstand how REITs really work. Some of the biggest REIT fears are far more nuanced than they seem. Today's setup may be creating overlooked opportunities.

The cannabis sector continues evolving in 2026, and REITs are gaining attention again. These companies offer exposure without directly selling cannabis. Instead, they generate income through leasing and financing properties. As a result, they often provide strong dividend yields for investors. Meanwhile, industry growth remains a key long-term catalyst.

NewLake Capital Partners offers high-yield REIT exposure to the cannabis sector, currently yielding over 12% with a healthy 84% payout ratio. NLCP trades at a significant discount (~0.75x book, 7x AFFO) due to OTCQX listing and regulatory overhang, providing a margin of safety. Regulatory reclassification of cannabis could double NLCP's valuation (to 15x AFFO), enable NYSE listing, and compress yields to ~8%.

NewLake Capital Partners, Inc. (NLCP) offers defensiveness and a 12% dividend yield, outperforming MSOS over the past three years. MSOS, an ETF heavily concentrated in top cannabis stocks, remains exposed to industry-wide oversupply, margin pressure, and bankruptcy risk. NLCP's low debt, resilient rent collections, and ability to replace tenants provide downside protection absent in MSOS.

NLCP has significantly underperformed since my initial bullish stance, with the stock price down over 26%. Despite collecting dividends, NLCP's total return remains negative at 9%, failing to offset capital losses. I maintained a bullish outlook and invested several times, but kept NLCP as a small portfolio position.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NLCP.
U.S. House Trading
No House trades found for NLCP.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
